Efficacy and safety of ultrasound-guided radiofrequency, microwave and laser ablation for the treatment of T1N0M0 papillary thyroid carcinoma on a large scale: a systematic review and meta-analysis

Reference

• Nabhan F, Dedhia PH, Ringel MD. Thyroid cancer, recent advances in diagnosis and therapy. Int J Cancer. 2021;149(5):984–992. doi: 10.1002/ijc.33690.
   PubMed Web of Science ®Google Scholar
• Wang J, Yu F, Shang Y, et al. Thyroid cancer: incidence and mortality trends in China, 2005–2015. Endocrine. 2020;68(1):163–173. doi: 10.1007/s12020-020-02207-6.
   PubMed Web of Science ®Google Scholar
• Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg. 2014;140(4):317–322. doi: 10.1001/jamaoto.2014.1.
   PubMed Web of Science ®Google Scholar
• Cabanillas ME, McFadden DG, Durante C. Thyroid cancer. Lancet. 2016;388(10061):2783–2795. doi: 10.1016/S0140-6736(16)30172-6.
   PubMed Web of Science ®Google Scholar
• Anderson KL, Youngwirth LM, Scheri RP, et al. T1a versus T1b differentiated thyroid cancers: do we need to make the distinction? Thyroid. 2016;26(8):1046–1052. doi: 10.1089/thy.2016.0073.
   PubMed Web of Science ®Google Scholar
• Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133. doi: 10.1089/thy.2015.0020.
   PubMed Web of Science ®Google Scholar
• Kanona H, Virk JS, Offiah C, et al. Ultrasound-guided assessment of thyroid nodules based on the 2014 british thyroid association guidelines for the management of thyroid cancer—how we do it. Clin Otolaryngol. 2017;42(3):723–727. doi: 10.1111/coa.12621.
   PubMed Web of Science ®Google Scholar
• Haymart MR, Esfandiari NH, Stang MT, et al. Controversies in the management of low-risk differentiated thyroid cancer. Endocr Rev. 2017;38(4):351–378. doi: 10.1210/er.2017-00067.
   PubMed Web of Science ®Google Scholar
• Lan Y, Luo Y, Zhang M, et al. Quality of life in papillary thyroid microcarcinoma patients undergoing radiofrequency ablation or surgery: a comparative study. Front Endocrinol (Lausanne). 2020;11:249. doi: 10.3389/fendo.2020.00249.
   PubMed Web of Science ®Google Scholar
• Mauri G, Hegedüs L, Bandula S, et al. European thyroid association and cardiovascular and interventional radiological society of Europe 2021 clinical practice guideline for the use of minimally invasive treatments in malignant thyroid lesions. Eur Thyroid J. 2021;10(3):185–197. doi: 10.1159/000516469.
   PubMed Web of Science ®Google Scholar
• Yi Z, Siyu L, Lijun F, et al. Efficacy, safety, and controversy of ultrasound-guided radiofrequency ablation in the treatment of T1N0M0 papillary thyroid carcinoma. Front Oncol. 2022;12:1068210. doi: 10.3389/fonc.2022.1068210.
   PubMed Web of Science ®Google Scholar
• Zu Y, Liu Y, Zhao J, et al. A cohort study of microwave ablation and surgery for low-risk papillary thyroid microcarcinoma. Int J Hyperthermia. 2021;38(1):1548–1557. doi: 10.1080/02656736.2021.1996643.
   PubMed Web of Science ®Google Scholar
• Li J, Liu Y, Liu J, et al. Ultrasound-guided percutaneous microwave ablation versus surgery for papillary thyroid microcarcinoma. Int J Hyperthermia. 2018;34(5):653–659. doi: 10.1080/02656736.2018.1453092.
   PubMed Web of Science ®Google Scholar
• Wang MH, Liu X, Wang Q, et al. Safety and efficacy of ultrasound-guided thermal ablation in treating T1aN0M0 and T1bN0M0 papillary thyroid carcinoma: a meta-analysis. Front Endocrinol (Lausanne). 2022;13:952113. doi: 10.3389/fendo.2022.952113.
   PubMed Web of Science ®Google Scholar
• Tong M, Li S, Li Y, et al. Efficacy and safety of radiofrequency, microwave and laser ablation for treating papillary thyroid microcarcinoma: a systematic review and meta-analysis. Int J Hyperthermia. 2019;36(1):1278–1286.
   PubMed Web of Science ®Google Scholar
• Xiao J, Zhang M, Zhang Y, et al. Efficacy and safety of ultrasonography-guided radiofrequency ablation for the treatment of T1bN0M0 papillary thyroid carcinoma: a retrospective study. Int J Hyperthermia. 2020;37(1):392–398. doi: 10.1080/02656736.2020.1752945.
   PubMed Web of Science ®Google Scholar
• Mauri G, Pacella CM, Papini E, et al. Image-guided thyroid ablation: proposal for standardization of terminology and reporting criteria. Thyroid. 2019;29(5):611–618. doi: 10.1089/thy.2018.0604.
   PubMed Web of Science ®Google Scholar
• Yan L, Zhang M, Song Q, et al. Clinical outcomes of radiofrequency ablation for multifocal papillary thyroid microcarcinoma versus unifocal papillary thyroid microcarcinoma: a propensity-matched cohort study. Eur Radiol. 2022;32(2):1216–1226. doi: 10.1007/s00330-021-08133-z.
   PubMed Web of Science ®Google Scholar
• Zhang C, Yin J, Hu C, et al. Comparison of ultrasound guided percutaneous radiofrequency ablation and open thyroidectomy in the treatment of low-risk papillary thyroid microcarcinoma: a propensity score matching study. CH. 2022;80(2):73–81. doi: 10.3233/CH-201087.
   Web of Science ®Google Scholar
• Yan L, Li X, Li Y, et al. Comparison of ultrasound-guided radiofrequency ablation versus thyroid lobectomy for T1bN0M0 papillary thyroid carcinoma. Eur Radiol. 2022;33(1):730–740. doi: 10.1007/s00330-022-08963-5.
   PubMed Web of Science ®Google Scholar
• He H, Song Q, Lan Y, et al. Efficacy and safety of ultrasound-guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma in patients aged 55 years or older: a retrospective study. Int J Hyperthermia. 2021;38(1):604–610. doi: 10.1080/02656736.2021.1912416.
   PubMed Web of Science ®Google Scholar
• He H, Wu R, Zhao J, et al. Ultrasound-guided radiofrequency ablation versus surgical resection for the treatment of T1bN0M0 papillary thyroid carcinoma in different age groups. Front Endocrinol. 2021;12:734432. doi: 10.3389/fendo.2021.734432.
   PubMed Web of Science ®Google Scholar
• Song Q, Gao H, Ren L, et al. Radiofrequency ablation versus total thyroidectomy in patients with papillary thyroid microcarcinoma located in the isthmus: a retrospective cohort study. Int J Hyperthermia. 2021;38(1):708–714. doi: 10.1080/02656736.2021.1916625.
   PubMed Web of Science ®Google Scholar
• Xiao J, Zhang Y, Yan L, et al. Ultrasonography-guided radiofrequency ablation for solitary T1aN0M0 and T1bN0M0 papillary thyroid carcinoma: a retrospective comparative study. Eur J Endocrinol. 2022;186(1):105–113. doi: 10.1530/EJE-21-0580.
   Web of Science ®Google Scholar
• Xiao J, Zhang Y, Zhang M, et al. Ultrasonography-guided radiofrequency ablation vs. surgery for the treatment of solitary T1bN0M0 papillary thyroid carcinoma: a comparative study. Clin Endocrinol. 2021;94(4):684–691. doi: 10.1111/cen.14361.
   PubMed Web of Science ®Google Scholar
• Yan L, Lan Y, Xiao J, et al. Long-term outcomes of radiofrequency ablation for unifocal low-risk papillary thyroid microcarcinoma: a large cohort study of 414 patients. Eur Radiol. 2021;31(2):685–694. doi: 10.1007/s00330-020-07128-6.
   PubMed Web of Science ®Google Scholar
• Yan L, Zhang M, Song Q, et al. Ultrasound-Guided radiofrequency ablation versus thyroid lobectomy for low-risk papillary thyroid microcarcinoma: a propensity-matched cohort study of 884 patients. Thyroid. 2021;31(11):1662–1672. doi: 10.1089/thy.2021.0100.
   PubMed Web of Science ®Google Scholar
• Yan L, Zhang M, Song Q, et al. The efficacy and safety of radiofrequency ablation for bilateral papillary thyroid microcarcinoma. Front Endocrinol. 2021;12:663636. doi: 10.3389/fendo.2021.663636.
   PubMed Web of Science ®Google Scholar
• Cho SJ, Baek SM, Lim HK, et al. Long-term follow-up results of ultrasound-guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma: more than 5-year follow-up for 84 tumors. Thyroid. 2020;30(12):1745–1751. doi: 10.1089/thy.2020.0106.
   PubMed Web of Science ®Google Scholar
• Song Q, Gao H, Tian X, et al. Evaluation of ultrasound-guided radiofrequency ablation as a treatment option for papillary thyroid microcarcinoma in the isthmus: a retrospective study. Front Endocrinol. 2021;11:599471. doi: 10.3389/fendo.2020.599471.
   PubMed Web of Science ®Google Scholar
• Wu R, Luo Y, Tang J, et al. Ultrasound-guided radiofrequency ablation for papillary thyroid microcarcinoma: a retrospective analysis of 198 patients. Int J Hyperthermia. 2020;37(1):168–174. doi: 10.1080/02656736.2019.1708480.
   PubMed Web of Science ®Google Scholar
• Zhang M, Tufano RP, Russell JO, et al. Ultrasound-guided radiofrequency ablation versus surgery for low-risk papillary thyroid microcarcinoma: results of over 5 years’ follow-up. Thyroid. 2020;30(3):408–417. doi: 10.1089/thy.2019.0147.
   PubMed Web of Science ®Google Scholar
• Ding M, Tang X, Cui D, et al. Clinical outcomes of ultrasound-guided radiofrequency ablation for the treatment of primary papillary thyroid microcarcinoma. Clin Radiol. 2019;74(9):712–717. doi: 10.1016/j.crad.2019.05.012.
   PubMed Web of Science ®Google Scholar
• Lim HK, Cho SJ, Baek JH, et al. US-Guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma: efficacy and safety in a large population. Korean J Radiol. 2019;20(12):1653–1661. doi: 10.3348/kjr.2019.0192.
   PubMed Web of Science ®Google Scholar
• Wei Y, Niu WQ, Zhao ZL, et al. Microwave ablation versus surgical resection for solitary T1N0M0 papillary thyroid carcinoma. Radiology. 2022;304(3):704–713. doi: 10.1148/radiol.212313.
   PubMed Web of Science ®Google Scholar
• Zheng L, Liu FY, Yu J, et al. Thermal ablation for papillary thyroid microcarcinoma located in the isthmus: a study with 3 years of follow-up. Future Oncol (London, England). 2022;18(4):471–480. doi: 10.2217/fon-2021-0463.
   PubMed Web of Science ®Google Scholar
• Lu C, Li X, Chu X, et al. Clinical effects of microwave ablation in the treatment of low-risk papillary thyroid microcarcinomas and related histopathological changes. Front Endocrinol. 2021;12:751213. doi: 10.3389/fendo.2021.751213.
   PubMed Web of Science ®Google Scholar
• Cao XJ, Zhao ZL, Wei Y, et al. Microwave ablation for papillary thyroid cancer located in the thyroid isthmus: a preliminary study. Int J Hyperthermia. 2021;38(1):114–119. doi: 10.1080/02656736.2021.1880028.
   PubMed Web of Science ®Google Scholar
• Wang X, Niu X, Mu S, et al. Analysis and evaluation of the efficacy of ultrasound-guided microwave ablation for papillary thyroid microcarcinoma. Int J Hyperthermia. 2021;38(1):1476–1485. doi: 10.1080/02656736.2021.1988152.
   PubMed Web of Science ®Google Scholar
• Wu J, Zhao ZL, Cao XJ, et al. A feasibility study of microwave ablation for papillary thyroid cancer close to the thyroid capsule. Int J Hyperthermia. 2021;38(1):1217–1224. doi: 10.1080/02656736.2021.1962549.
   PubMed Web of Science ®Google Scholar
• Teng DK, Li WH, Du JR, et al. Effects of microwave ablation on papillary thyroid microcarcinoma: a five-year follow-up report. Thyroid. 2020;30(12):1752–1758. doi: 10.1089/thy.2020.0049.
   PubMed Web of Science ®Google Scholar
• Yue WW, Qi L, Wang DD, et al. US-guided microwave ablation of low-risk papillary thyroid microcarcinoma: longer-term results of a prospective study. J Clin Endocrinol Metab. 2020;105(6):1791–1800. doi: 10.1210/clinem/dgaa128.
   Web of Science ®Google Scholar
• Li J, Liu Y, Liu J, et al. A comparative study of short-term efficacy and safety for thyroid micropapillary carcinoma patients after microwave ablation or surgery. Int J Hyperthermia. 2019;36(1):640–646.
   PubMed Web of Science ®Google Scholar
• Teng DK, Li HQ, Sui GQ, et al. Preliminary report of microwave ablation for the primary papillary thyroid microcarcinoma: a large-cohort of 185 patients feasibility study. Endocrine. 2019;64(1):109–117. doi: 10.1007/s12020-019-01868-2.
   PubMed Web of Science ®Google Scholar
• Teng D, Sui G, Liu C, et al. Long-term efficacy of ultrasound-guided low power microwave ablation for the treatment of primary papillary thyroid microcarcinoma: a 3-year follow-up study. J Cancer Res Clin Oncol. 2018;144(4):771–779. doi: 10.1007/s00432-018-2607-7.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang GP, Zhan WW, et al. The feasibility and efficacy of ultrasound-guided percutaneous laser ablation for multifocal papillary thyroid microcarcinoma. Front Endocrinol. 2022;13:921812. doi: 10.3389/fendo.2022.921812.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Chung SM, Kim H, et al. Long-term efficacy of ultrasound-guided laser ablation for papillary thyroid microcarcinoma: results of a 10-year retrospective study. Thyroid. 2021;31(11):1723–1729. doi: 10.1089/thy.2021.0151.
   PubMed Web of Science ®Google Scholar
• Peng K, Zhou P, Liu W. Long-term efficacy of ultrasound-guided percutaneous laser ablation for low-risk papillary thyroid microcarcinoma: a 5-year follow-up study. Biomed Res Int. 2021;2021:1–8. doi: 10.1155/2021/6616826.
   PubMed Web of Science ®Google Scholar
• Ji L, Wu Q, Gu J, et al. Ultrasound-guided percutaneous laser ablation for papillary thyroid microcarcinoma: a retrospective analysis of 37 patients. Cancer Imaging. 2019;19(1):16. doi: 10.1186/s40644-019-0204-x.
   PubMed Web of Science ®Google Scholar
• Zhou W, Ni X, Xu S, et al. Ultrasound-guided laser ablation versus surgery for solitary papillary thyroid microcarcinoma: a retrospective study. Int J Hyperthermia. 2019;36(1):897–904.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhou W, Zhan W, et al. Percutaneous laser ablation of unifocal papillary thyroid microcarcinoma: utility of conventional ultrasound and contrast-enhanced ultrasound in assessing local therapeutic response. World J Surg. 2018;42(8):2476–2484. doi: 10.1007/s00268-018-4500-6.
   PubMed Web of Science ®Google Scholar
• Li T, Lu B, Zhang Y, et al. Meta-analysis of the application effect of different modalities of thermal ablation and surgical treatment in papillary thyroid microcarcinoma. Dis Markers. 2022;2022:9714140. doi: 10.1155/2022/9714140.
   PubMed Web of Science ®Google Scholar
• Choi Y, Jung SL. Efficacy and safety of thermal ablation techniques for the treatment of primary papillary thyroid microcarcinoma: a systematic review and meta-analysis. Thyroid. 2020;30(5):720–731. doi: 10.1089/thy.2019.0707.
   PubMed Web of Science ®Google Scholar
• Chen Y, Sadow PM, Suh H, et al. BRAF(V600E) is correlated with recurrence of papillary thyroid microcarcinoma: a systematic review, multi-institutional primary data analysis, and meta-analysis. Thyroid. 2016;26(2):248–255. doi: 10.1089/thy.2015.0391.
   PubMed Web of Science ®Google Scholar
• Xing M, Liu R, Liu X, et al. BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence. J Clin Oncol. 2014;32(25):2718–2726. doi: 10.1200/JCO.2014.55.5094.
   PubMed Web of Science ®Google Scholar
• Yue W, Chen L, Yu L, et al. Checkpoint blockade and nanosonosensitizer-augmented noninvasive sonodynamic therapy combination reduces tumour growth and metastases in mice. Nat Commun. 2019;10(1):2025. doi: 10.1038/s41467-019-09760-3.
   PubMed Web of Science ®Google Scholar
• Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14(3):199–208. doi: 10.1038/nrc3672.
   PubMed Web of Science ®Google Scholar
• Lan X, Sun W, Zhang H, et al. A meta-analysis of central lymph node metastasis for predicting lateral involvement in papillary thyroid carcinoma. Otolaryngol Head Neck Surg. 2015;153(5):731–738. doi: 10.1177/0194599815601412.
   PubMed Web of Science ®Google Scholar
• Min Y, Wang X, Chen H, et al. Thermal ablation for papillary thyroid microcarcinoma: how far we have come? Cancer Manag Res. 2020;12:13369–13379. doi: 10.2147/CMAR.S287473.
   PubMed Web of Science ®Google Scholar
• Orloff LA, Noel JE, Stack BC, Jr., et al. Radiofrequency ablation and related ultrasound-guided ablation technologies for treatment of benign and malignant thyroid disease: an international multidisciplinary consensus statement of the American Head and Neck Society Endocrine Surgery Section with the Asia Pacific Society of Thyroid Surgery, Associazione Medici Endocrinologi, British Association of Endocrine and Thyroid Surgeons, European Thyroid Association, Italian Society of Endocrine Surgery Units, Korean Society of Thyroid Radiology, Latin American Thyroid Society, and Thyroid Nodules Therapies Association. Head Neck. 2022;44(3):633–660. doi: 10.1002/hed.26960.
   PubMed Web of Science ®Google Scholar
• Yekuo L, Shasha W, Feng H. Multipolar radiofrequency ablation in controlling hemorrhage from blunt liver trauma. Am J Emerg Med. 2009;27(2):197–201. doi: 10.1016/j.ajem.2008.01.060.
   PubMed Web of Science ®Google Scholar
• Oda H, Miyauchi A, Ito Y, et al. Incidences of unfavorable events in the management of low-risk papillary microcarcinoma of the thyroid by active surveillance versus immediate surgery. Thyroid. 2016;26(1):150–155. doi: 10.1089/thy.2015.0313.
   PubMed Web of Science ®Google Scholar
• Mauri G, Orsi F, Carriero S, et al. Image-Guided thermal ablation as an alternative to surgery for papillary thyroid microcarcinoma: preliminary results of an Italian experience. Front Endocrinol (Lausanne). 2020;11:575152. doi: 10.3389/fendo.2020.575152.
   PubMed Web of Science ®Google Scholar
• Tufano RP, Pace-Asciak P, Russell JO, et al. Update of radiofrequency ablation for treating benign and malignant thyroid nodules. The future is now. Front Endocrinol (Lausanne). 2021;12:698689. doi: 10.3389/fendo.2021.698689.
   PubMed Web of Science ®Google Scholar
• Yan L, Zhang Y, Jiang B, et al. Radiofrequency ablation for cervical metastatic lymph nodes in children and adolescents with papillary thyroid carcinoma: a preliminary study. Front Endocrinol (Lausanne). 2021;12:624054. doi: 10.3389/fendo.2021.624054.
   PubMed Web of Science ®Google Scholar
• Lan Y, Jin Z, Zhang M[, et al. Factors affecting quality of life of patients undergoing radiofrequency ablation for papillary thyroid microcarcinoma]. Zhongguo yi Xue ke Xue Yuan Xue Bao (Acta Acad Med Sin). 2020;42(5):632–639.
   PubMedGoogle Scholar
• Ou D, Chen C, Jiang T, et al. Research review of thermal ablation in the treatment of papillary thyroid carcinoma. Front Oncol. 2022;12:859396. doi: 10.3389/fonc.2022.859396.
   PubMed Web of Science ®Google Scholar